Cargando…
Coupled Genome-Wide DNA Methylation and Transcription Analysis Identified Rich Biomarkers and Drug Targets in Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) has poor clinical prognosis. Lack of TNBC-specific biomarkers prevents active clinical intervention. We reasoned that TNBC must have its specific signature due to the lack of three key receptors to distinguish TNBC from other types of breast cancer. We also reaso...
Autores principales: | Guo, Maoni, Sinha, Siddharth, Wang, San Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896154/ https://www.ncbi.nlm.nih.gov/pubmed/31690011 http://dx.doi.org/10.3390/cancers11111724 |
Ejemplares similares
-
Genome Instability-Derived Genes Are Novel Prognostic Biomarkers for Triple-Negative Breast Cancer
por: Guo, Maoni, et al.
Publicado: (2021) -
Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer
por: Meyer, Braydon, et al.
Publicado: (2021) -
Targeting DNA methylation for treating triple-negative breast cancer
por: Yu, Jia, et al.
Publicado: (2019) -
Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder Cancer()
por: Olkhov-Mitsel, Ekaterina, et al.
Publicado: (2017) -
Genome-wide chromatin accessibility, DNA methylation and gene expression analysis of histone deacetylase inhibition in triple-negative breast cancer
por: Bustos, Matias A., et al.
Publicado: (2017)